Abstract
Rhizoma Atractylodes macrocephala, Radix Isatidis, Coptis chinensis and Flos Genkwa are common herbal remedies used by pregnant woman in China. In this study, their potential embryotoxicity was assessed using the embryonic stem cell test (EST) and a prediction model. The potential embryotoxicity of the herbs was based on three endpoints: the concentrations of the compounds that inhibited the proliferation of 50% of embryonic stem cells (ESCs) ($IC_{50}ES$), the concentrations that inhibited 50% of 3T3 cells ($IC_{50}3T3$), and the concentrations that inhibited the differentiation of 50% of ESCs ($ID_{50}ES$). The results revealed that Rhizoma Atractylodes macrocephala and Radix Isatidis are non-embryotoxic compounds. Coptis chinensis extracts appeared to demonstrated weak embryotoxicity, and Flos Genkwa exhibited strong embryotoxicity. These results may be useful in guiding the clinical use of these herbs and in expanding the application of the EST to the field of traditional Chinese medicine.
Introduction
While Traditional Chinese Medicine (TCM) is often perceived as a "natural" and low-toxicity alternative to conventional pharmaceuticals, its safety profile during pregnancy remains under-researched. Many pregnant women utilize herbal remedies for morning sickness or threatened preterm labor, yet systematic developmental toxicity data is scarce. Traditional in vivo teratogenicity tests are expensive, time-consuming, and raise significant ethical concerns regarding animal welfare. This study addresses the need for a reliable, high-throughput in vitro screening method—the Embryonic Stem Cell Test (EST)—to identify herbal extracts that might pose a risk to fetal development.
Materials and Methods
The study evaluated aqueous extracts of four specific herbs: Rhizoma Atractylodes macrocephala (Baizhu), Radix Isatidis (Banlangen), Coptis chinensis (Huanglian), and Flos Genkwa (Yuanhua). To validate the model, researchers used Saccharin (non-toxic), Phenytoin (weakly toxic), and 5-Fluorouracil (strongly toxic) as control chemicals.
The Embryonic Stem Cell Test (EST)
Unlike standard cytotoxicity assays, the EST evaluates a substance's ability to interfere with cellular differentiation. The researchers utilized the OG2 mouse ESC line, validating its pluripotency before testing.
The EST utilizes three primary endpoints:
- $IC_{50}3T3$: Concentration inhibiting the growth of 3T3 fibroblasts (adult somatic cells) by 50%.
- $IC_{50}ES$: Concentration inhibiting the growth of embryonic stem cells (ESCs) by 50%.
- $ID_{50}ES$: Concentration inhibiting the differentiation of ESCs into beating cardiomyocytes by 50%.
These values were processed through a mathematical prediction model (linear discriminant functions) to classify each herb as non-embryotoxic (Class 1), weakly embryotoxic (Class 2), or strongly embryotoxic (Class 3).
Results
The study successfully validated the EST model using control substances. For example, 5-Fluorouracil (5-FU) was correctly identified as strongly embryotoxic based on its significant inhibition of both cell survival and differentiation at low concentrations.
The classification of the four herbs is summarized in the table below:
| Herb | $IC_{50}3T3$ (mg/ml) | $IC_{50}ES$ (mg/ml) | $ID_{50}ES$ (mg/ml) | Classification |
|---|---|---|---|---|
| Atractylodes | 4.82 | 42.42 | 37.67 | Non-embryotoxic |
| R. Isatidis | 1.76 | 27.68 | 15.00 | Non-embryotoxic |
| C. chinensis | 0.40 | 2.73 | 1.06 | Weakly embryotoxic |
| Flos Genkwa | 0.51 | 0.75 | 1.15 | Strongly embryotoxic |
Discussion
A key insight from this study is that differentiation is often the most sensitive metric; for several herbs, the $ID_{50}$ was significantly lower than the $IC_{50}$, proving that a substance can disrupt development without necessarily killing cells. The "weakly embryotoxic" classification of Coptis chinensis provides modern toxicological evidence supporting existing regional bans on its use during pregnancy. Furthermore, the high potency of Flos Genkwa reinforces its traditional use as an abortifacient.
While the EST is a robust screening tool, it does not account for maternal metabolism or the potential toxicity of fat-soluble compounds not present in aqueous extracts. Future research should expand to other differentiation pathways (e.g., neural) and investigate the specific molecular mechanisms of the identified toxins.
Summary updated